Advantage of cerebellar intermittent theta-burst stimulation in Alzheimer's disease (ACT-AD): study protocol for a multicenter, randomized, double-blind, sham-controlled trial
Authors:
Open Access
- 9 October 2026
- journal article
- research article
- Published by Springer Nature in Trials
- Vol. 27 (1) , 601
Abstract
Introduction: The cerebellum plays a crucial role in cognitive processing and thus presents a promising therapeutic target for Alzheimer’s disease (AD). This trial aims to evaluate the efficacy and safety of long-term, neuronavigated cerebellar intermittent theta burst stimulation (iTBS) in patients with AD. Methods and analysis: The ACT-AD trial is a multicenter, randomized, double-blind, sham-controlled study involving 100 participants with mild-to-moderate AD across 4 centers in China. Participants will be randomized to receive either cerebellar iTBS or sham stimulation for 4 weeks (daily sessions), followed by 8 weeks of weekly maintenance sessions. The primary outcome is the change in the Clinical Dementia Rating Scale Sum of Boxes (CDR-SB) score from baseline to week 12. Secondary outcomes include additional clinical scales. Exploratory outcomes include electroencephalogram (EEG), blood biomarkers and magnetic resonance imaging (MRI). Statistical analysis will follow intention-to-treat principles using mixed models for repeated measures (MMRM). Discussion: The ACT-AD trial will assess the efficacy and safety of long-term, neuronavigated cerebellar iTBS in treating patients with mild-to-moderate AD. Trial registration: ClinicalTrials.gov, NCT06669182. Registered on 31 October 2024.Keywords
Funding Information
- Clinical Research Program of the Fourth Military Medical University (2024LC2419)
This publication has 44 references indexed in Scilit:
- Cerebellum in Alzheimer's disease and other neurodegenerative diseases: an emerging research frontierMedcomm, 2024
- Effect of cerebellum stimulation on cognitive recovery in patients with Alzheimer disease: A randomized clinical trialBrain Stimulation, 2022
- Toward noninvasive brain stimulation 2.0 in Alzheimer’s diseaseAgeing Research Reviews, 2021
- Effects of Cerebellar Theta Burst Stimulation on Contralateral Motor Cortex Excitability in Patients with Alzheimer’s DiseaseBrain Topography, 2020
- Cerebellar repetitive transcranial magnetic stimulation (rTMS) for essential tremor: A double-blind, sham-controlled, crossover, add-on clinical trialBrain Stimulation, 2020
- Functional Brain Connectivity Using fMRI in Aging and Alzheimer’s DiseaseNeuropsychology Review, 2014
- The cerebellum: Its role in language and related cognitive and affective functionsBrain and Language, 2013
- Repetitive transcranial magnetic stimulation combined with cognitive training is a safe and effective modality for the treatment of Alzheimer’s disease: a randomized, double-blind studyJournal of Neural Transmission, 2012
- From Movement to Thought: Executive Function, Embodied Cognition, and the CerebellumThe Cerebellum, 2011
- Functional Topography of the Cerebellum in Verbal Working MemoryNeuropsychology Review, 2010